Monday, August 4, 2025

Latest

Trulieve Posts Q2 Net Loss Of $407 Million Due To Asset Impairments

The stateside cannabis sector continues to follow the path of the Canadian cannabis sector, with Trulieve Cannabis (CSE: TRUL) this morning reporting a massive net loss for the second quarter of 2023 as a result of goodwill impairments.

The company saw a net loss of $406.9 million for the second quarter, driven in large part by the impairment of goodwill to the tune of $307.6 million. The impairment was triggered by the recent share price performance of the company, rather than as a result of the operations themselves. Excluding discontinued operations, disposals, impairments, and non-recurring charges, Trulieve reported an “adjusted net loss” of $15 million.

Revenue declined on a quarter over quarter basis for the multi state operator, dropping from $289 million to $282 million, with the company noting that price compression is becoming a factor in its revenue growth.

On a year over year basis, revenue declined 10% from $314 million. This decline comes as the company has exited its California retail assets and commenced a wind down of its operations in Massachusetts in an effort to preserve cash.

“We are on track to exit this year as a leaner, stronger organization, ready to meet the opportunities ahead,” commented CEO Kim Rivers.

Gross profit declined from $150 million to $142 million sequentially, while margins dropped two percentage points to 50%.

READ: Trulieve Cannabis Sees CFO Quit After Just Ten Days On The Job

SG&A expenses however also fell, dropping from $102 million to $96 million, before factoring in the goodwill impairment.

Adjusted EBITDA for the quarter came in at $79 million, an improvement over the $78 million figure reported in the first quarter, while cash flow from operations excluding tax payments rose to $98 million year to date. Despite this, the firms cash position declined from $195 million to $160 million over the course of the second quarter.

Total current assets declined from $574.2 million to $474.8 million during the quarter, while total current liabilities increased from $188.3 million to $240.6 million.

Trulieve Cannabis last traded at $5.69 on the CSE.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

San Dimas: First Majestic Silver’s Sleeper Asset

New Gold Q2 Earnings: Record Free Cash Flow

STLLR Gold: The Tower Gold PEA

Recommended

Tsunami Warnings Spread As Largest Quake Since 2011 Hits Russia

Northern Superior Intersects 1.75 g/t Gold Over 65.0 Metres At Philibert

Related News

Trulieve Reveals Former CFO Was Reimbursed Up To $400k In Personal Expenses

It appears that Trulieve Cannabis (CSE: TRUL) is having more problems with the chief financial...

Wednesday, August 9, 2023, 12:36:06 PM

Trulieve Q3 Earnings: Amendment 3 Fails

Trulieve (CSE: TRUL) has reported its third quarter earnings results. And while the stock may...

Wednesday, November 6, 2024, 03:36:00 PM

Aurora Cannabis Earnings Illustrated: Empty Calories Giving The Market A Sugar High

The Deep Dive’s West Coast office was pretty happy to have shoveled dirt on Aurora...

Monday, May 18, 2020, 01:37:57 PM

Trulieve: Canaccord Increases Estimates Following Q2 Results

On August 12, Trulieve Cannabis (CSE: TRUL) reported their second quarter financials. The company announced...

Saturday, August 14, 2021, 12:56:00 PM

Trulieve Loses Out On West Virginia Growers Permit Application

It appears that a false start for Trulieve Cannabis (CSE: TRUL) was fired in West...

Saturday, October 3, 2020, 12:03:38 PM